WallStreetZenWallStreetZen
Analyst Ranking
Top 3%
#121 out of 4176 analysts
Average Return
+17.58%
Win Rate
47%48 out of 102
Risk vs Reward
Poor
Good

Jay Olson's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
89bio IncETNB
+476.89%$2.64$15.23
2022-05-12 -
2023-03-31
Buy
89bio IncETNB
+372.98%$3.22$15.23
2022-06-29 -
2023-03-31
Buy
Prothena Corp Public Ltd CoPRTA
+357.12%$12.08$55.22
2020-07-08 -
2021-07-08
Buy
Madrigal Pharmaceuticals IncMDGL
+275.95%$64.44$242.26
2022-05-09 -
2023-03-31
Buy
Biovie IncBIVI
+227.40%$2.81$9.20
2022-03-14 -
2023-03-14
Buy

Jay Olson Analyst Color

Get additional color on Jay Olson's coverage of popular stocks

Jay Olson's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Viking Therapeutics IncVKTX
1Buy$30.00+80.18%Maintains
4 days ago
Cognition Therapeutics IncCGTX
2Buy$9.00+354.55%Reiterates
8 days ago
Seagen IncSGEN
8Buy$229.00+13.10%Maintains
18 days ago
Voyager Therapeutics IncVYGR
3Buy$14.00+81.58%Initiates Coverage On
23 days ago
Cymabay Therapeutics IncCBAY
2Buy$12.00+37.61%Maintains
25 days ago
Nektar TherapeuticsNKTR
2Hold$3.00+326.74%Maintains
a month ago
Denali Therapeutics IncDNLI
2Buy$70.00+203.82%Maintains
a month ago
Acadia Pharmaceuticals IncACAD
5Hold$20.00+6.27%Maintains
a month ago
Revolution Medicines IncRVMD
2Buy$35.00+61.59%Maintains
a month ago
Madrigal Pharmaceuticals IncMDGL
3Buy$300.00+23.83%Maintains
a month ago
Intellia Therapeutics IncNTLA
5Buy$93.00+149.53%Maintains
a month ago
Crispr Therapeutics AgCRSP
4Buy$102.06+125.65%Maintains
a month ago
89bio IncETNB
3Buy$18.00+18.19%Maintains
a month ago
Biogen IncBIIB
11Buy$310.00+11.50%Maintains
a month ago
Biovie IncBIVI
2Buy$12.00+48.51%Reiterates
2 months ago
Amgen IncAMGN
9Buy$294.00+21.61%Maintains
2 months ago
Mirati Therapeutics IncMRTX
5Hold$60.00+61.38%Maintains
4 months ago
Cincor Pharma IncCINC
3HoldN/AN/ADowngrades
4 months ago
Editas Medicine IncEDIT
3Hold$12.00+65.52%Downgrades
4 months ago
Jasper Therapeutics IncJSPR
2Buy$8.00+341.99%Maintains
5 months ago
Ayala Pharmaceuticals IncAYLA
4HoldN/AN/ADowngrades
5 months ago
Relmada Therapeutics IncRLMD
2HoldN/AN/ADowngrades
6 months ago
Prothena Corp Public Ltd CoPRTA
7Buy$110.00+126.94%Maintains
6 months ago
Enanta Pharmaceuticals IncENTA
4Hold$59.00+45.90%Maintains
8 months ago
Sierra Oncology IncSRRA
2Hold$55.00+0.02%Downgrades
a year ago
Neurocrine Biosciences IncNBIX
4Buy$154.00N/AMaintains
a year ago
Sage Therapeutics IncSAGE
4Buy$80.00N/AMaintains
a year ago
Incyte CorpINCY
6Buy$109.00N/AMaintains
a year ago
Exelixis IncEXEL
1Buy$29.00N/AMaintains
a year ago
Focus Financial Partners IncFOCS
1Buy$71.00N/AMaintains
a year ago
Frequency Therapeutics IncFREQ
2Buy$20.00N/AMaintains
2 years ago
Karuna Therapeutics IncKRTX
3Buy$148.00N/AMaintains
2 years ago
Intercept Pharmaceuticals IncICPT
1Hold$46.00N/ADowngrades
3 years ago
Bicycle Therapeutics PLCBCYC
1Buy$27.00N/AInitiates Coverage On
3 years ago
Tempest Therapeutics IncTPST
1Hold$2.00N/ADowngrades
3 years ago
Marinus Pharmaceuticals IncMRNS
2Buy$24.00N/AInitiates Coverage On
3 years ago
Mediwound LtdMDWD
1Buy$84.00N/AMaintains
5 years ago
Acorda Therapeutics IncACOR
2Hold$126.00N/AMaintains
5 years ago
Medicines CoMDCO
2BuyN/AN/AUpgrades
5 years ago
Neuroderm LtdNDRM
2Buy$42.00N/AUpgrades
6 years ago
Therapeuticsmd IncTXMD
1HoldN/AN/ADowngrades
6 years ago
Portola Pharmaceuticals IncPTLA
1BuyN/AN/AUpgrades
6 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.